PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Holden Comprehensive Cancer Center, University of Iowa, College of Medicine, Iowa City, IA, USA.\', \'Department of Pathology, University of Iowa, College of Medicine, Iowa City, IA, USA.\', \'Cancer Biology Graduate Program, University of Iowa, College of Medicine, Iowa City, IA, USA.\', \'Medical Scientist Training Program, University of Iowa, College of Medicine, Iowa City, IA, USA.\', \'Department of Internal Medicine, University of Iowa, College of Medicine, Iowa City, IA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2147/DDDT.S282252
?:hasPublicationType
?:journal
  • Drug design, development and therapy
is ?:pmid of
?:pmid
?:pmid
  • 33239864
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.974
?:rankingScore_hIndex
  • 40
?:title
  • Repurposing Anti-Cancer Drugs for COVID-19 Treatment.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all